Lyme Carditis AV Block Risk Score Calculator

Clinical calculation support · Verify results before clinical use

SILC clinical assessment

Select each finding present in the patient. This score estimates suspicion for Lyme carditis in patients presenting with high-degree AV block.

0of 12 points
1

Sex

Male sex is one of the clinical features included in the proposed SILC score.

Male: +1 point
2

Age under 50 years

Select yes if the patient is younger than 50 years.

Yes: +1 point
3

Outdoor activity or residence/travel in an endemic area

Consider relevant outdoor exposure or a geographic setting where Lyme disease is endemic.

Yes: +1 point
4

Constitutional symptoms

For example, fever, malaise, arthralgia, or myalgia.

Yes: +2 points
5

Known or suspected tick bite

A tick bite may not always be recalled; assess exposure history clinically.

Yes: +3 points
6

Erythema migrans rash

Current or previous rash clinically compatible with erythema migrans.

Yes: +4 points

PR interval is not included in the SILC score. In a patient with suspected Lyme carditis, PR ≥300 ms is a marker of severe disease and warrants urgent hospital assessment and continuous ECG monitoring.

0of 12 points
SILC suspicion category
Low suspicion score
A low score does not exclude Lyme carditis. Interpret in the context of the presentation and local epidemiology.
Clinical interpretation and next stepsUse clinical judgement. If the presentation is compatible with Lyme carditis, do not use the score alone to rule it out.

SILC was proposed for patients presenting with high-degree AV block. It is a suspicion aid, not a diagnostic test, and its specificity could not be assessed in the original systematic review because a control group was unavailable.

About the SILC score

The Suspicious Index in Lyme Carditis (SILC) is a proposed clinical risk-stratification tool to help clinicians consider Lyme carditis in patients presenting with high-degree atrioventricular block. It should support, not replace, clinical assessment.

Variables and points

VariableCriterionPoints
SexMale+1
AgeUnder 50 years+1
Outdoor activity / endemic areaPresent+1
Constitutional symptomsPresent+2
Tick biteKnown or suspected+3
Erythema migransCurrent or prior compatible rash+4

Score interpretation

TotalCategory
0–2Low suspicion
3–6Intermediate suspicion
7–12High suspicion

These categories describe suspicion for Lyme carditis, not the severity of AV block or a validated probability of disease. The original SILC report was based on published cases and did not include a control group to estimate specificity.

Clinical considerations

  • Ask about cardiac symptoms including palpitations, dyspnea, chest discomfort, light-headedness, presyncope, and syncope.
  • In suspected Lyme carditis, significant PR prolongation (≥300 ms), higher-degree AV block, other arrhythmias, or evidence of myopericarditis should prompt urgent hospital assessment and continuous ECG monitoring.
  • Do not delay appropriate treatment when clinical suspicion is high while awaiting confirmatory test results.
  • Management route and antibiotic choice depend on clinical severity and current guidelines; this calculator does not prescribe a regimen.

References

Besant G, Wan D, Yeung C, et al. Suspicious index in Lyme carditis: Systematic review and proposed new risk score. Clinical Cardiology. 2018;41(12):1611–1616. doi:10.1002/clc.23102
Branda JA, et al. / IDSA, AAN, and ACR guideline panel. Clinical Practice Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease. Clinical Infectious Diseases. 2021;72(1):e1–e48. doi:10.1093/cid/ciaa1215
Centers for Disease Control and Prevention (CDC). Clinical Care and Treatment of Lyme Carditis. Official clinical guidance.
Clinical disclaimer: This tool is for clinician support and education. SILC is a proposed, non-prospectively validated score and should not be used as the sole basis for diagnosis, antibiotic selection, admission, pacing decisions, or exclusion of Lyme carditis. Use current local guidance, patient-specific assessment, ECG findings, and appropriate infectious disease/cardiology consultation.